Newsletter July 2021 No.204
Top News
The 38th Pharmaceutical Manufacturers Association of Japan (PMAJ) Press Conference was held.
On May 20, 2021, the "Pharmaceutical Association of Japan Press Conference" was held at Hotel Metropolitan Edmont (Chiyoda-ku, Tokyo). At the press conference, Yasushi Okada, newly elected chairman of the Pharmaceutical Manufacturers Association of Japan (PMAJ) at the 260th PMAJ General Assembly held on the same day, expressed his belief in the industry and discussed the severe challenges the industry faces and the efforts the PMAJ will focus on in the future, marking a fresh start under the new chairman Okada. Although the press conference was webcast, it was attended by 36 members of the media, who engaged in a lively Q&A session, showing a high level of interest in the future direction of the pharmaceutical industry.
Topics
- The 10th APAC (Asian Association of Pharmaceutical Manufacturers and Associations) Conference -Mission: Delivering Innovative Medicines to the People of Asia Quickly - Theme: "Overcoming COVID-19 and Toward a Decade of New Innovative Challenges in Asia
- JPMA Media Forum on New Coronavirus Pandemic Reaffirms Need for Novel Antimicrobial Agents Against Drug Resistance (AMR)
- The "Regular Meeting with the European Federation of Pharmaceutical Industries and Associations (EFPIA)" was held.
- Joint Meeting of the Drug Evaluation Committee and the Pharmaceutical Affairs Committee for 2021" was held.
- JPMA/PhRMA/EFPIA Joint Press Conference: Proposals for the Formulation of a "Framework Policy" and "Vision for the Pharmaceutical Industry
- COVID-19 Session" jointly held by PMDA and the Pharmaceutical Manufacturers Association of Japan (PMAJ) at DIA China 2021
Policy Research Institute page
From JPMA
On assuming the position of Chairman